Study Finds How Lithium Helps Treat Bipolar Disorders

It has emerged that American researchers have made an advance towards uncovering lithium's mode of action as it treats bipolar disorders

It has emerged that American researchers have made an advance towards uncovering lithium's mode of action as it treats bipolar disorders.

The new research has provided solid evidence that lithium reduces brain inflammation by adjusting the metabolism of the health-protective omega-3-fatty acid called DHA.

About Schizophrenia
Schizophrenia is a mental disorder characterized by symptoms of thought, behavior and social problems.

Inflammation in the brain, like other parts of the body, is an important process to help the brain combat infection or injury.

However, excess or unwanted inflammation can damage sensitive brain cells, which can contribute to psychiatric conditions like bipolar disorder or degenerative diseases like Alzheimers.

It's believed that lithium helps treat bipolar disorder by reducing brain inflammation during the manic phase, thus alleviating some of the symptoms.

Brain�s 'Default Mode' Awry in Schizophrenia
The 'default mode,' or baseline condition when the brain is idling, is not properly coordinated in patients with schizophrenia

Exactly how lithium operates, though, has been debated.

Mireille Basselin and colleagues at the National Institute of Aging and University of Colorado, Denver, took a detailed approach to this question by using mass spectrometry analysis to analyse the chemical composition of brain samples of both control and lithium-treated rats stressed by brain inflammation.

Advertisements

Australians Urged to Stop Swearing for Schizophrenia Awareness Week
Aussies are being asked to give up swearing for one whole week to help raise money for schizophrenia research.

They found that in agreement with some other studies, rats given a six-week lithium treatment had reduced levels of arachidonic acid and its products, which can contribute to inflammation.

Moreover, they also demonstrated, for the first time, that lithium treatment increased levels of a metabolite called 17-OH-DHA in response to inflammation. 17-OH-DHA is formed from the omega-3 fatty acid DHA (docosahexaenoic acid) and is the precursor to a wide range of anti-inflammatory compounds known as docosanoids.

Advertisements

Link Between Brain Chemical, Cognitive Decline in Schizophrenia Demonstrated by UC Davis Researchers
Researchers at UC Davis have provided evidence that deficits in a brain chemical may be responsible for some of the debilitating cognitive deficits that are the hallmarks of schizophrenia

Other anti-inflammatory drugs, like aspirin, are known to also enhance docosanoids in their mode of action.

Basselin and colleagues noted that the concentration of DHA did not increase, which suggests that lithium may increase 17-OH-DHA levels by affecting the enzyme that converts DHA to 17-OH-DHA.

By reducing both pro-inflammatory AA products, and increasing anti-inflammatory DHA products, lithium exerts a double-protective effect which may explain why it works well in bipolar treatment.

The study has appeared in the May 2010 Journal of Lipid Research.

Source-ANI
RAS /